Search Results 3441-3450 of 26144 for oral

  1. Chronic Intestinal Pseudo Obstruction de novo Clinical Outcomes Assessment

    Capable of oral nutrition (including partial oral nutrition). Currently resides in US. Ability to read, speak and understand English (US English) fluently ...

  2. Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Subjects With Hypoparathyroidism - Mayo Clinic

    History of hypoparathyroidism · Requirement for supplemental oral calcium treatment ≥ 1000 mg per day. · Requirement for active vitamin D therapy at a dose of ≥ ...

  3. A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma - Mayo Clinic

    Oral prednisone at a dose of 10 mg or less per day is allowed, as are other oral corticosteroids given at glucocorticoid-equivalent doses. Topical, nasal ...

  4. Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) - Mayo Clinic

    ... (oral vs rectal vs both oral and rectal); (3) role of oral budesonide in patients mild-moderate UC; (4) comparative effectiveness and tolerability of rectal ...

  5. Small bowel cancer - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

  6. Licensure Policy

    #Oral and Maxillofacial Surgery trainees must complete final licensing exam within first. 10 months after medical school graduation. Training Completion ...

  7. Small bowel cancer - Doctors and departments - Mayo Clinic

    ... Oral biopsy, Cancer, Head and neck cancer, Facial fracture, Osteoradionecrosis, Chondrosarcoma, Nasal and paranasal tumors, Thyroid cancer, Soft tissue ...

  8. Diarrhea Clinical Trials - Mayo Clinic Research

    To evaluate the safety and effectiveness of oral ... 608 patients with Clostridium Difficile Associated Diarrhea (CDAD) will participate in this study and receive ...

  9. 2 22 Poland audio_only

    Gazelka 22:05. And as a point of clarity, Greg, there is quite a difference between taking steroid orally and having it injected into a localized area. My ...

  10. Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Mayo Clinic

    Secondary ICH related to known causes (e.g., trauma, aneurysm, arteriovenous malformation (AVM), oral anticoagulant use (vitamin K antagonists or novel oral ...